ATTAIN-2

A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes

OrforglipronCompletedCompletedPhase 3Open NCT05872620 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…